FDA Clears J&J’s Ethicon Monarch Robotic System For Urology Procedures

J&J’s entry into the kidney stone management market will not threaten Boston Scientific’s leadership position in that market in the near-term, according to Wells Fargo analyst Larry Biegelsen.